Q1 2014 Holdings
Filed 2014-05-13 | 61 holdings | $94.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $53.2M | 173,983 | 56.6% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $28.7M | 421,384 | 30.6% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $7.0M | 731,943 | 7.5% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $4.1M | 61,595 | 4.4% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $106.6K | 1,504,712 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $65.9K | 472,046 | 0.1% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $63.4K | 211,166 | 0.1% |
| Amgen, Inc.(AMGN) | Common | 031162100 | $55.4K | 449,543 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $51.1K | 335,899 | 0.1% |
| Actavis plc | Shares | G0083B108 | $42.3K | 205,707 | 0.0% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $35.3K | 499,764 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $31.8K | 652,209 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $29.9K | 558,080 | 0.0% |
| Allergan, Inc. | Common | 018490102 | $26.8K | 216,337 | 0.0% |
| Perrigo Company plc(PRGO) | Shares | G97822103 | $26.0K | 167,874 | 0.0% |
| Ishares Nasdaq Biotechnology(IBB) | ETF | 464287556 | $24.1K | 102,080 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $22.9K | 154,153 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $19.4K | 185,820 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $18.5K | 246,841 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $16.6K | 226,772 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $16.5K | 311,476 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $15.4K | 103,841 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $15.4K | 699,382 | 0.0% |
| Forest Laboratories, Inc. | Common | 345838106 | $13.5K | 146,500 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $12.0K | 67,862 | 0.0% |
| Catamaran Corporation | Common | 148887102 | $10.3K | 231,000 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $9.9K | 918,827 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $9.8K | 286,540 | 0.0% |
| Celladon Corporation | Common | 15117E107 | $9.8K | 970,495 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | Common | 427746102 | $9.7K | 696,597 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $9.5K | 768,050 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $9.5K | 404,731 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $9.1K | 344,683 | 0.0% |
| Endo International PLC | Shares | G30401106 | $8.7K | 126,215 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $8.6K | 194,870 | 0.0% |
| Questcor Pharmaceuticals, Inc. | Common | 74835Y101 | $7.6K | 117,080 | 0.0% |
| PerkinElmer, Inc.(RVTY) | Common | 714046109 | $7.5K | 165,495 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $7.2K | 59,660 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $6.9K | 427,790 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $6.8K | 56,265 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $6.8K | 82,436 | 0.0% |
| IntelliPharmaCeutics International Inc. | Common | 458173101 | $6.2K | 1,404,000 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $5.8K | 683,260 | 0.0% |
| Pharmacyclics, Inc. | Common | 716933106 | $5.5K | 55,125 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $4.3K | 112,881 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | Common | 45665G303 | $4.2K | 349,899 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $3.9K | 105,000 | 0.0% |
| Merrimack Pharmaceuticals, Inc. | Common | 590328100 | $3.8K | 757,050 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $3.7K | 60,000 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | $3.3K | 72,520 | 0.0% |